The Psychedelic Report

Understanding the Impact of the FDA Vote on MDMA Therapy with Rachel Nuwer

Jun 10, 2024
Guest
Rachel Nuwer
Esteemed journalist Rachel Nuwer discusses the FDA vote on MDMA-assisted therapy, critiquing the committee's decision and highlighting the benefits of MDMA in enhancing therapy outcomes. The conversation emphasizes the importance of accurate reporting and increased awareness to advance psychedelic therapies and build public trust.
Ask episode
Chapters
Transcript
Episode notes
1
Intro
00:00 • 5min
2
FDA Meeting on MDMA Therapy and Clinical Trials
05:21 • 8min
3
Impact of FDA Vote on MDMA Therapy for PTSD Treatment
13:50 • 12min
4
Patient Safety and MDMA Therapy FDA Vote Impact
25:27 • 6min
5
Optimism and Importance of MDMA Therapy Approval
31:54 • 4min